Assessing Stroke and Bleeding Risk in Atrial Fibrillation–Consensus Statement Executive Summary

This executive summary shares the critical conclusions from the expert consensus statement that makes important recommendations on the use of stroke and bleeding risk tools, the decision to anticoagulate, the incorporation of patient preferences, and more.  Read the full consensus.

The experts include Mark J. Alberts, MD; Mary Amantangelo, MS, ACNP-BC, CCRN; Kenneth A. Bauer, MD; Lynne T. Braun, PhD, CNP, FAHA; Henry I. Bussey, PharmD; A. John Camm, MD, QHP, FRCP, FACC, FESC, FMedSci, FHRS, CStJ; David Garcia, MD; Samuel Z. Goldhaber, MD; Jonathan L. Halperin, MD; Mellanie True Hills; Alan K. Jacobson, MD; Gregory Y.H. Lip, MD, FRCP, FESC, FACC; Edith A. Nutescu, PharmD, FCCP; Daniel E. Singer, MD; Albert L. Waldo, MD, FACC, FAHA, FHRS, FAACP